In 2025, JAMA highlighted studies shaping medical practice, notably showing GLP-1 drugs cut hospitalization or death in heart failure patients by over 40%, and that shingles...
Giftify [NASDAQ: GIFT] is disrupting the GLP-1 market with a smart savings model providing consumers with discounted Ozempic and Wegovy. With the FDA closing the loophole...